Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate prefilled injection versus methotrexate tablets in adults with active rheumatoid arthritis
ChiCTR2200066425Phase 3Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of methotrexate in rheumatoid arthritis (RA) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Reduction in DAS28-ESR from baseline at week 12. Started Nov 2021; status: completed.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ChiCTR2200066425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066425.